EUDA Health Holdings stock reports Q2 revenue of USD 1.73 million

EUDA Health Holdings stock has a fresh earnings marker: Q2 2026 revenue was USD 1.73 million and EPS was USD -0.17, according to MarketBeat on September 29, 2026. The same earnings report identifies the company as Nasdaq-listed EUDA Health and places the announcement after the market close.

Six month revenue rose 13.43 percent

EUDA's latest interim filing gives the broader operating picture. Revenue for the six months ended June 30, 2026, reached USD 3,467,835, compared with USD 3,057,323 in the same 2025 period, an increase of 13.43 percent.

StockTitan reports that property management contributed USD 2,255,161 and holistic wellness products and services generated USD 1,212,674 during the period. The revenue increase therefore came with a still loss-making cost structure rather than a shift to profitability.

Loss narrowed but cash remains central

Net loss for the six-month period was USD 796,950, down from USD 1,201,696 a year earlier, a 33.71 percent reduction. The filing also shows net cash used in operating activities of USD 1,206,041, which exceeded the USD 365,904 cash balance reported at June 30, 2026.

The filing adds a significant financing signal: management said conditions created substantial doubt about EUDA's ability to continue as a going concern within one year after the financial statements were issued. That disclosure gives the revenue comparison a sharper investor meaning, because operating growth has not yet removed the need for additional funding.

Market value reflects a small-cap profile

EUDA Health Holdings had a market capitalization of USD 29.7 million as of September 29, 2026. The company operates in healthcare, with activities spanning property management and holistic wellness products and services across parts of Asia.

Financial risk sets the next checkpoint

The September 29 filing combines a 13.43 percent revenue increase with USD 1.2 million of operating cash use and a formal going-concern warning. For investors, the next material checkpoint is whether revenue conversion and outside financing can improve liquidity after the six-month reporting period.